Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer

SR Denmeade, CM Jakobsen, S Janssen, SR Khan, ES Garrett, Hans Lilja, SB Christensen, JT Isaacs

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science